| Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents MW Wlodarski, S Hirabayashi, V Pastor, J Starý, H Hasle, R Masetti, ... Blood, The Journal of the American Society of Hematology 127 (11), 1387-1397, 2016 | 407 | 2016 |
| Collaborative efforts driving progress in pediatric acute myeloid leukemia CM Zwaan, EA Kolb, D Reinhardt, J Abrahamsson, S Adachi, R Aplenc, ... Journal of clinical oncology 33 (27), 2949, 2015 | 379 | 2015 |
| Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia N Toft, H Birgens, J Abrahamsson, L Griškevičius, H Hallböök, M Heyman, ... Leukemia 32 (3), 606-615, 2018 | 361 | 2018 |
| The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation GK Pandey, S Mitra, S Subhash, F Hertwig, M Kanduri, K Mishra, ... Cancer cell 26 (5), 722-737, 2014 | 338 | 2014 |
| High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset H Carén, H Kryh, M Nethander, RM Sjöberg, C Träger, S Nilsson, ... Proceedings of the National Academy of Sciences 107 (9), 4323-4328, 2010 | 273 | 2010 |
| Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate J Abrahamsson, E Forestier, J Heldrup, K Jahnukainen, OG Jónsson, ... Journal of Clinical Oncology 29 (3), 310-315, 2011 | 230 | 2011 |
| Emergence of New ALK Mutations at Relapse of Neuroblastoma G Schleiermacher, N Javanmardi, V Bernard, Q Leroy, J Cappo, ... Journal of Clinical Oncology 32 (25), 2727-2734, 2014 | 225 | 2014 |
| Long-term results in children with AML: NOPHO-AML Study Group–report of three consecutive trials SO Lie, J Abrahamsson, N Clausen, E Forestier, H Hasle, L Hovi, ... Leukemia 19 (12), 2090-2100, 2005 | 178 | 2005 |
| Acute leukaemia in children with Down syndrome: a population‐based Nordic study B Zeller, G Gustafsson, E Forestier, J Abrahamsson, N Clausen, J Heldrup, ... British journal of haematology 128 (6), 797-804, 2005 | 176 | 2005 |
| Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol N Toft, H Birgens, J Abrahamsson, P Bernell, L Griškevičius, H Hallböök, ... European journal of haematology 90 (5), 404-412, 2013 | 152 | 2013 |
| Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO‐AML trials SO Lie, J Abrahamsson, N Clausen, E Forestier, H Hasle, L Hovi, ... British Journal of Haematology 122 (2), 217-225, 2003 | 142 | 2003 |
| High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous … H Carén, J Erichsen, L Olsson, C Enerbäck, RM Sjöberg, J Abrahamsson, ... BMC genomics 9, 1-13, 2008 | 128 | 2008 |
| Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group T Ek, L Mellander, B Andersson, J Abrahamsson Pediatric blood & cancer 44 (5), 461-468, 2005 | 123 | 2005 |
| Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004 H Hasle, J Abrahamsson, E Forestier, SY Ha, J Heldrup, K Jahnukainen, ... Blood, The Journal of the American Society of Hematology 120 (5), 978-984, 2012 | 121 | 2012 |
| No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic … UM Saarinen-Pihkala, G Gustafsson, O Ringdén, C Heilmann, ... Journal of clinical oncology 19 (14), 3406-3414, 2001 | 113 | 2001 |
| PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers MM Ali, VS Akhade, ST Kosalai, S Subhash, L Statello, M Meryet-Figuiere, ... Nature communications 9 (1), 883, 2018 | 108 | 2018 |
| Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia A Staffas, M Kanduri, R Hovland, R Rosenquist, HB Ommen, ... Blood, The Journal of the American Society of Hematology 118 (22), 5905-5913, 2011 | 106 | 2011 |
| Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: Multi‐institutional collaborative study BM Frost, S Eksborg, O Björk, J Abrahamsson, M Behrendtz, A Castor, ... Medical and Pediatric Oncology: The Official Journal of SIOP—International …, 2002 | 104 | 2002 |
| Improved outcome after relapse in children with acute myeloid leukaemia J Abrahamsson, N Clausen, G Gustafsson, L Hovi, G Jonmundsson, ... British journal of haematology 136 (2), 229-236, 2007 | 101 | 2007 |
| Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapy T Martinsson, T Eriksson, J Abrahamsson, H Caren, M Hansson, ... Cancer research 71 (1), 98-105, 2011 | 97 | 2011 |
Tommy MartinssonProfessor of Cancer Genetics, University of Gothenburg, Göteborg, SwedenVerified email at gu.se
